Last updated on August 2018

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants with Overactive Bladder and Urinary Incontinence


Brief description of study

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants with Overactive Bladder and Urinary Incontinence

Detailed Study Description

Key Inclusion Criteria:

  • Has symptoms of OAB (frequency and urgency) with urgency urinary incontinence for a period of at least 6 months immediately prior to screening

Clinical Study Identifier: TX152811

Find a site near you

Start Over

Manhattan Medical Research

215 Lexington Ave. 21st Floor New York, NY USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.